ZA200202655B - Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. - Google Patents

Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Info

Publication number
ZA200202655B
ZA200202655B ZA200202655A ZA200202655A ZA200202655B ZA 200202655 B ZA200202655 B ZA 200202655B ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 B ZA200202655 B ZA 200202655B
Authority
ZA
South Africa
Prior art keywords
hexahydrofuro
ylsulfonyl
benzodioxol
furan
carbamate
Prior art date
Application number
ZA200202655A
Other languages
English (en)
Inventor
Piet Tom Bert Paul Wigerinck
Guangyang Wang
Michael Eissenstat
John W Erickson
Original Assignee
Tibotec Pharm Ltd
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd, Nat Inst Health filed Critical Tibotec Pharm Ltd
Publication of ZA200202655B publication Critical patent/ZA200202655B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200202655A 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. ZA200202655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ZA200202655B true ZA200202655B (en) 2003-09-23

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202655A ZA200202655B (en) 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Country Status (25)

Country Link
US (2) US6649651B1 (cs)
EP (1) EP1222192B8 (cs)
JP (1) JP4951179B2 (cs)
KR (1) KR100792391B1 (cs)
CN (1) CN1191256C (cs)
AP (1) AP1459A (cs)
AT (1) ATE398623T1 (cs)
AU (1) AU781656B2 (cs)
BR (1) BR0014602A (cs)
CA (1) CA2386850C (cs)
CZ (1) CZ300031B6 (cs)
DE (1) DE60039244D1 (cs)
DK (1) DK1222192T3 (cs)
ES (1) ES2307533T3 (cs)
HU (1) HU228938B1 (cs)
IL (2) IL149005A0 (cs)
MX (1) MXPA02003607A (cs)
NO (1) NO327996B1 (cs)
NZ (1) NZ518580A (cs)
OA (1) OA12053A (cs)
PL (1) PL204924B1 (cs)
RU (1) RU2247123C2 (cs)
SK (1) SK287153B6 (cs)
WO (1) WO2001025240A1 (cs)
ZA (1) ZA200202655B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398623T1 (de) * 1999-10-06 2008-07-15 Tibotec Pharm Ltd Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
US7244752B2 (en) 2001-04-09 2007-07-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
ATE453648T1 (de) * 2001-09-10 2010-01-15 Tibotec Pharm Ltd Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
EP1472536A4 (en) * 2002-01-07 2007-02-14 Sequoia Pharmaceuticals VERSATILE INHIBITORS
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
HRP20050607B1 (hr) 2002-05-17 2014-07-04 Tibotec Pharmaceuticals Ltd. Supstituirani benzizoksazol sulfonamid hiv proteazni inhibitori širokog spektra
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
AU2003275675A1 (en) 2002-12-27 2004-07-29 Sumitomo Chemical Company, Limited Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
MXPA06010365A (es) 2004-03-11 2007-05-04 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retrovirales repelentes a la resistencia.
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
MX2007010378A (es) 2005-02-25 2007-09-25 Tibotec Pharm Ltd Sintesis del precursor inhibidor de la proteasa.
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
AR061838A1 (es) 2006-07-07 2008-09-24 Gilead Sciences Inc Moduladores de propiedades farmacocineticas de terapeuticos
AU2007277253A1 (en) * 2006-07-24 2008-01-31 Gilead Sciences, Inc. Bisfuranyl protease inhibitors
US8153829B2 (en) 2006-11-09 2012-04-10 Janssen Pharmaceutica N.V. Methods for the preparation of hexahydrofuro[2,3-B]furan-3-ol
EP2491785A1 (en) * 2006-11-21 2012-08-29 Purdue Research Foundation Method and compositions for treating HIV infections
EP3689353A1 (en) 2007-02-23 2020-08-05 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
EP2134336B1 (en) 2007-03-16 2013-12-11 Sequoia Pharmaceuticals Benzofuran-derived hiv protease inhibitors
ES2438275T3 (es) 2007-07-06 2014-01-16 Gilead Sciences, Inc. Moduladores de propiedades farmacocinéticas de agentes terapéuticos
US8759379B2 (en) 2008-01-04 2014-06-24 Gilead Sciences, Inc. Inhibitors of cytochrome P450
EP2244571A4 (en) 2008-01-17 2014-02-19 Purdue Research Foundation SMALL MOLECULAR INHIBITORS OF HIV PROTEASES
EP2307345A4 (en) 2008-07-01 2012-05-02 Purdue Research Foundation NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
WO2010006050A1 (en) 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
RU2593790C2 (ru) 2009-12-21 2016-08-10 Янссен Сайенсиз Айрлэнд Юси Разлагаемый удаляемый имплантат для непрерывного высвобождения активного соединения
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
JPWO2014024898A1 (ja) 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE154800T1 (de) * 1992-08-25 1997-07-15 Searle & Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
WO1994004492A1 (en) * 1992-08-25 1994-03-03 G.D. Searle & Co. Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
AU7669794A (en) * 1993-08-24 1995-03-21 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt) * 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
ATE398623T1 (de) * 1999-10-06 2008-07-15 Tibotec Pharm Ltd Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Also Published As

Publication number Publication date
CA2386850C (en) 2010-03-30
EP1222192A1 (en) 2002-07-17
HUP0203130A2 (hu) 2003-01-28
AU7663800A (en) 2001-05-10
AP2002002472A0 (en) 2002-06-30
SK5702002A3 (en) 2003-01-09
PL354351A1 (en) 2004-01-12
SK287153B6 (sk) 2010-01-07
EP1222192B1 (en) 2008-06-18
EP1222192B8 (en) 2008-10-01
NZ518580A (en) 2004-01-30
US20050261364A1 (en) 2005-11-24
AU781656B2 (en) 2005-06-02
AP1459A (en) 2005-08-22
KR100792391B1 (ko) 2008-01-08
CN1191256C (zh) 2005-03-02
NO20021598D0 (no) 2002-04-04
IL149005A (en) 2006-12-31
HK1054746A1 (en) 2003-12-12
NO20021598L (no) 2002-05-29
OA12053A (en) 2006-05-02
DE60039244D1 (de) 2008-07-31
CZ20021419A3 (cs) 2002-10-16
US6649651B1 (en) 2003-11-18
NO327996B1 (no) 2009-11-02
ATE398623T1 (de) 2008-07-15
CZ300031B6 (cs) 2009-01-14
DK1222192T3 (da) 2008-10-20
IL149005A0 (en) 2002-11-10
BR0014602A (pt) 2002-06-11
RU2247123C2 (ru) 2005-02-27
HUP0203130A3 (en) 2005-01-28
ES2307533T3 (es) 2008-12-01
WO2001025240A1 (en) 2001-04-12
HU228938B1 (hu) 2013-06-28
PL204924B1 (pl) 2010-02-26
KR20020067503A (ko) 2002-08-22
JP2003511383A (ja) 2003-03-25
CN1407987A (zh) 2003-04-02
CA2386850A1 (en) 2001-04-12
JP4951179B2 (ja) 2012-06-13
US7157495B2 (en) 2007-01-02
MXPA02003607A (es) 2003-07-28

Similar Documents

Publication Publication Date Title
ZA200202655B (en) Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
WO1999064047A8 (en) Novel antiviral compounds
ZA200107496B (en) Amine derivatives as protease inhitors.
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
ZA200000075B (en) Enzymes mixture.
ZA200204283B (en) Novel antidiabetic agents.
ZA992344B (en) Game machine.
ZA991551B (en) 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines.
ZA200407817B (en) 2-(2,6-Dichlorophenyl)-diarylimidazoles.
ZA200004319B (en) Game machine.
ZA981602B (en) Novel hexanoic acid derivatives.
MXPA02005792A (es) 1-(aminofenil)-2-pirrolidonas como inhibidores de la integrina.
ZA992448B (en) Quinoxalinones as serine protease inhibitors.
ZA991548B (en) 6,9-Disubstituted 2-[trans-(4-Aminocyclohexyl) Amino] Purines.
ZA992445B (en) Benzoxazinones/benzothiazinones as serine protease inhibitors.
ZA985885B (en) External abrasive machine.
ZA200004373B (en) Game machine.
ZA200007631B (en) Hand-held environmental monitor.
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
ZA991268B (en) Novel sulfonamides.
ZA978552B (en) Retroviral protease inhibiting compounds.
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
MXPA02000261A (es) Aminoindanos novedosos.